Epijoint

Founded in Ballarat Victoria in 1998, Interpath Global has evolved into an internationally respected business supplying natural, innovative joint health products to customers around the world. Despite its global reach, the company remains proudly Australian and family-owned, with its headquarters still based in Ballarat. Committed to ongoing investment in world-class clinical research, product development and scientific excellence, Interpath continues its mission of helping both people and animals to live more active and fulfilling lives.

At the heart of Interpath’s success is its proprietary active ingredient called Epiitalis® which is an exclusive plant seed oil extract. Epiitalis® is the secret behind all Interpath products and is globally patented for both its anti-inflammatory properties and cartilage health benefits.

Interpath first established its reputation through the success of 4CYTE™, its veterinary joint health range for dogs, cats and horses. Today, 4CYTE™ is recognised as the most widely used natural joint health supplement for animals in Australia and Australasia and is considered the market leader within the veterinary joint health category.

Building on this success, Interpath launched Epijoint®, a human joint health brand via Chemist Warehouse in early 2024. Epijoint® offers a unique approach to supporting people experiencing joint pain, stiffness, inflammation and mild osteoarthritis symptoms. Unlike many conventional joint supplements, Epijoint® is backed by published clinical research demonstrating meaningful improvements in pain, mobility and quality of life, giving consumers confidence in an evidence-based, science-backed Australian product. Today, Epijoint® is rapidly establishing itself within the Australian consumer health market while also expanding internationally.